By now we’ve all heard about Martin Shkreli, CEO of Turing Pharmaceuticals who bought all the rights to a life-saving drug and jacked up the price more than 5,000 percent. What you probably haven’t heard is that U.S. policy protects price gougers like Shkreli, and with new provisions in the Trans Pacific Partnership, we’re going […]